EMPATECH MET

EMPATECH MET 12.5/500 is an advanced oral antidiabetic medication that combines Empagliflozin (12.5 mg) and Metformin Hydrochloride (500 mg) to offer dual glycemic control in patients with Type 2 Diabetes Mellitus. This fixed-dose combination is designed to help lower blood sugar levels effectively while offering added cardiovascular and renal protection. It is especially beneficial for patients who do not achieve adequate glycemic control with metformin alone.

Key Ingredients:

Empagliflozin (12.5 mg):
A SGLT2 inhibitor (Sodium-Glucose Co-Transporter-2 inhibitor) that works by promoting glucose excretion through the urine. It also contributes to weight loss and blood pressure reduction, offering multiple metabolic benefits.

Metformin Hydrochloride (500 mg):
A biguanide class antidiabetic, Metformin reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity, helping the body use insulin more efficiently.

Key Benefits:

• Provides effective blood glucose control in Type 2 Diabetes

• Helps in weight management due to reduced glucose reabsorption

• Supports cardiovascular health by lowering blood pressure and improving vascular outcomes

• Offers renal protection in patients with diabetic kidney complications

• Reduces the risk of hypoglycemia when taken without insulin or sulfonylureas

• Improves insulin sensitivity and decreases insulin resistance

• Convenient dual-action formula in a single tablet

How Does It Work?

EMPATECH MET 12.5/500 combines two complementary mechanisms:

• Empagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and allowing excess glucose to be eliminated through urine. This reduces blood glucose levels and can also aid in lowering body weight and blood pressure.

• Metformin acts primarily in the liver to decrease glucose production. It also improves the body’s response to insulin, promoting more effective glucose uptake by muscles and reducing blood sugar levels without causing weight gain.

Together, they provide comprehensive glycemic control with the added benefit of cardiovascular and renal protection.

Directions for Use:

• Take EMPATECH MET 12.5/500 as directed by your physician.

• Usually prescribed once or twice daily, preferably with meals to reduce gastrointestinal side effects.

• Swallow the tablet whole with a glass of water — do not crush or chew.

• Maintain a healthy diet and follow your doctor’s recommended exercise routine.

• Regular monitoring of blood glucose, renal function, and HbA1c is advised.

• Do not stop taking the medicine without consulting your doctor, even if your blood sugar improves.

Side Effects:

Common Side Effects:

• Increased urination

• Thirst or dehydration

• Nausea or diarrhea

• Genital or urinary tract infections

• Headache or fatigue

• Mild abdominal discomfort

Serious (but rare) Side Effects:

• Lactic acidosis (associated with metformin)

• Ketoacidosis (though rare, especially during illness or fasting)

• Hypoglycemia (when used with insulin or sulfonylureas)

• Impaired kidney function

• Allergic reactions such as rash, itching, or swelling

Seek immediate medical help if you experience symptoms such as difficulty breathing, muscle pain, severe weakness, unusual tiredness, or confusion.